NCT06253754 Pathophysiological Mechanisms and Implication of Treatment in Postural Puncture Headache
| NCT ID | NCT06253754 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Umeå University |
| Condition | Post-Dural Puncture Headache |
| Study Type | OBSERVATIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-01-30 |
| Primary Completion | 2027-12-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 160 participants in total. It began in 2024-01-30 with a primary completion date of 2027-12-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To improve treatment for post dural puncture headache, its pathophysiology needs to be explored. Dural puncture alters CNS dynamics; using advanced MRI, we aim to investigate PDPHs pathophysiology explained by brain movement, cerebral blood flow, CSF dynamics and the effect of epidural blood patch.
Eligibility Criteria
Inclusion Criteria: Postural puncture headache Age 20-40 Exclusion Criteria: * Other central neurological disorders except the actual * Acute medical condition * Pregnancy * Pacemaker, or other medical implants that are not MRI-compatible * Invasive procedures on the central nervous system or surgery on the spine or brain in the last 12 months.
Contact & Investigator
Laleh Zarrinkoob, MD, PhD
PRINCIPAL INVESTIGATOR
Umeå University
Frequently Asked Questions
Who can join the NCT06253754 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Post-Dural Puncture Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06253754 currently recruiting?
Yes, NCT06253754 is actively recruiting participants. Contact the research team at erik.burman@regionvasterbotten.se for enrollment information.
Where is the NCT06253754 trial being conducted?
This trial is being conducted at Umeå, Sweden.
Who is sponsoring the NCT06253754 clinical trial?
NCT06253754 is sponsored by Umeå University. The principal investigator is Laleh Zarrinkoob, MD, PhD at Umeå University. The trial plans to enroll 160 participants.